# Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects

> **NCT01924182** · NA · TERMINATED · sponsor: **MedtronicNeuro** · enrollment: 7 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DEVICE:** SynchroMed Infusion System and Intrathecal Morphine Sulfate
- **OTHER:** Conventional Medicine

## Key facts

- **NCT ID:** NCT01924182
- **Lead sponsor:** MedtronicNeuro
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Amendment changes were significant enough to warrant a new study.
- **Last updated:** 2018-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01924182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01924182, "Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01924182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*